GENE ONLINE|News &
Opinion
Blog

Editors' Picks
Asia Pacific APAC
Cross-Border Trust and Transparency: The New Landscape of Bridging the Regulatory Review in the Asia-Pacific
2025-04-23
Asia-Pacific APAC
Unlocking the Gut Code: Japan’s Pharmaceutical Sector Explores the Future of Microbiome Therapeutics
2025-04-23
Conferences GMP Inspection Reliance
Advancing Pharmaceutical Regulatory Cooperation in Asia: The Vision and Challenges of GMP Inspection Reliance
2025-04-23
In-Depth Cancer
From Cancer to Cosmetics, Physiological to Pathological – The Field of Exosomes Full of Endless Opportunities
Exosomes, with their unique properties, are generating increasing interest for their clinical applications across drug delivery, regenerative medicine, and disease diagnosis. Companies are exploring innovative …

Home Read More »

2025-04-22
Conferences drug labellinge-labelling
The Digital Revolution of Drug Labelling: FHIR and the Global Blueprint for e-Labelling
2025-04-23
Special
Asia-Pacific APAC
Unlocking the Gut Code: Japan’s Pharmaceutical Sector Explores the Future of Microbiome Therapeutics
At a recent session hosted by the Japan Pharmaceutical Manufacturers Association (JPMA), experts from academia, industry, and regulatory agencies gathered to delve into the mysteries …

Unlocking the Gut Code: Japan’s Pharmaceutical Sector Explores the Future of Microbiome Therapeutics Read More »

2025-04-23
Pharma Eli LillyGLP-1 receptor agonist
Eli Lilly’s Orforglipron Shows Phase 3 Success: First Oral GLP-1 Drug for Type 2 Diabetes and Weight Loss
U.S. pharmaceutical giant Eli Lilly and Company announced good news on April 17 that its once-daily oral small molecule GLP-1 receptor agonist. Orforglipron has successfully …

Eli Lilly’s Orforglipron Shows Phase 3 Success: First Oral GLP-1 Drug for Type 2 Diabetes and Weight Loss Read More »

2025-04-21
Special Exosomes
Exosomes: The Small Couriers Moving Beyond Traditional Drug Delivery
Over the years, drug delivery systems like liposomes, micelles, and synthetic nanoparticles have helped improve the way medications are absorbed and distributed in the body. …

Exosomes: The Small Couriers Moving Beyond Traditional Drug Delivery Read More »

2025-04-17
LATEST
Arkansas Medicaid Work Requirements Led to Coverage Loss for a Significant Number of Recipients
2025-04-24
Boehringer agrees new partnership to advance first-in-class precision cancer therapies
2025-04-24
Bristol Myers Squibb Schizophrenia Drug Fails Pivotal Test as an Add-On to Antipsychotics
2025-04-24
Obesity Throws Metabolism Timing Off Balance
2025-04-24
Psychedelic Sparks Long-Term Brain Plasticity
2025-04-24
Clearing Zombie Cells Eases Back Pain
2025-04-24
Middle-Aged Americans Are the Loneliest, Global Study Finds
2025-04-24
READ MORE
Deals
Funding
Special
Sen-Jam’s First-in-Class FDA-Regulated Hangover Cure Enters Phase 2 Trials
2024-11-20
VerImmune Completes $4.5 Million First Closing of Pre-Series A Financing, Strengthens Board with Two Accomplished Biotechnology Executives
2024-09-22
$115M Series A Boosts Myricx Bio’s ADC Development with Lilly and Novo Support
2024-07-11
IPO
IPO Ascentage Pharma
China’s Ascentage Snatches First Biotech IPO Price of 2025, Raking in $126M
2025-01-24
CNS Drug-Maker Reviva Announces $18M Public Offering of Common Stock and Warrants to Fund R&D
2024-12-17
DualityBio, Partner of BioNTech and BeiGene, Files for Hong Kong IPO, Highlighting Several Potential First-in-Class ADCs
2024-08-29
M&A
M&A BMS
Bristol Myers Squibb Acquires Cancer Cell Therapy Partner 2seventy Bio in $286M Deal
2025-03-12
The Stargate Project: A $500 Billion Initiative that Will Bring Tech Giants to the AI Table
2025-01-24
Neuro, Pain, and Cancer Top the List at JPM 2025 Healthcare Conference
2025-01-17
Ranking & Reports
Ranking & Reports
Industry Pharma layoffs
Layoffs in Biotech and Pharma: A March 2025 Snapshot by Therapeutic and Technology Focus
2025-04-03
2024 EU Industrial R&D Investment Scoreboard Highlights 9.8% Increase in R&D Spending
2024-12-30
Global Trade Wars and Innovation Shake Up the Life Sciences Industry
2024-11-06
Categories
Interviews
Interviews Parkinson's Disease Awareness Day
Living Well with Parkinson’s: A Chronic Condition, Not a Life Sentence
2025-04-11
New Philippines NGS Center Targets Critical Gaps in Genomic Care
2025-03-31
Fast-Tracking Biotech Innovation: How ITRI Is Overcoming Bottlenecks and Fueling Taiwan’s Global Startup Boom
2025-03-19
Asia-Pacific
Asia Pacific Conference
Inside the Exosome Boom: Global Experts Talk Industry Trends, Roadblocks, and What’s Next
2025-04-16
South Korea’s Olix Strikes $660M Deal with Eli Lilly for Phase 1 MASH candidate
2025-02-11
Crossing Borders for a New Era in Medical Service Standards: Highlights from the 1st Asia Pacific Forum on Healthcare Quality
2024-12-12
Trials & Approvals
Trials & Approvals Alzheimer's Drug
Leqembi Makes History as First EU-Approved Drug to Target Root Cause of Alzheimer’s Disease
2025-04-15
Breaking New Ground in 2025 with 8 First-in-Class Drugs Close to FDA Approval – Part I
2025-03-31
Double Win With FDA’s Green Light Towards Two New Denosumab Biosimilars
2025-03-05
China
China biotech industry
China’s Biotech Industry Is Having Its Moonshot Moment
2025-04-14
Chinese Researchers Decode Autoimmune Mechanisms of Myasthenia Gravis
2025-04-11
China Blocks Illumina’s Sequencers as U.S. Tariffs Double–Trade War Fallout Intensifies
2025-03-06
Startups
Interviews UC Berkeley
Innovation Alone Doesn’t Guarantee Market Success – An Interview with UC Berkeley’s Darren Cooke
2025-02-24
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
Discover the Next Billion-Dollar Unicorn at the Biotech Innovation Funding Networking Event
2024-03-21
Manufacturing
Manufacturing MerckFacility
Merck Launches $1 Billion Vaccine Facility in North Carolina, Boosting U.S. Manufacturing and Job Creation
2025-03-13
BioNTech’s Bold Move: Rwanda’s New mRNA Vaccine Factory Set to Boost African Healthcare
2024-11-06
JPMA on Japan’s Biotech Industry: Cancer, Cardiovascular, and Aging Lead Diseases; Antibody, Cell, and Gene Therapies Top the Innovation List
2024-10-17
Licensing
Licensing FDA
FDA in Review: What’s Next for Biosimilars, Generic Drugs, and the Orange Book?
2025-01-27
Drug Promotion, Nonprescription Pathways, and Advanced Manufacturing: FDA’s Key Focus Areas in 2024 and What’s Next for 2025
2025-01-23
The First-Ever Nasal Spray for Anaphylactic Shock Gets FDA Approval
2024-08-12
R&D
Pharma Eli LillyGLP-1 receptor agonist
Eli Lilly’s Orforglipron Shows Phase 3 Success: First Oral GLP-1 Drug for Type 2 Diabetes and Weight Loss
2025-04-21
Trump Moves to Slam Tariffs on Pharma and Semiconductors Over National Security Fears
2025-04-15
Pfizer Halts Oral GLP-1 Drug Danuglipron Development Amid Liver Safety Concerns
2025-04-15
Technology
Trending Trump Administration
Trump Moves to Slam Tariffs on Pharma and Semiconductors Over National Security Fears
2025-04-15
Extinct No More? Scientists Successfully Birth the Once-Lost Dire Wolf
2025-04-11
Healthcare Through the Eyes of AI: Coding the Future of Medicine Through Digital Acceleration
2025-03-21
EVENT
2025-04-21
World Vaccine Congress Washington 2025
Washington, U.S.A
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
2025-04-26
SABPA OC/LA 17th Annual Biomedical Forum
Irvine, California, United States
2025-05-03
29th Taiwan Joint Cancer Conference 2025
Taipei, Taiwan
2025-05-05
Swiss Biotech Day 2025
Basel, Switzerland
2025-05-13
ASGCT 28th Annual Meeting 2025
New Orleans, U.S.A.
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2025 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top